Cargando…
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir
BACKGROUND: The role of the antiviral therapy in treatment of COVID-19 is still a matter to be investigated. Also efficacy and safety of antiviral regimens were not compared according severity of the disease. In this study the efficacy and safety of hydroxychloroquine plus atazanavir/ritonavir was c...
Autores principales: | Rahmani, Hamid, Davoudi-Monfared, Effat, Nourian, Anahid, Nabiee, Morteza, Sadeghi, Setayesh, Khalili, Hossein, Abbasian, Ladan, Ghiasvand, Fereshteh, Seifi, Arash, Hasannezhad, Malihe, Ghaderkhani, Sara, Mohammadi, Mostafa, Yekaninejad, Mir Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7453126/ https://www.ncbi.nlm.nih.gov/pubmed/32857301 http://dx.doi.org/10.1007/s40199-020-00369-2 |
Ejemplares similares
-
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
por: Toroghi, Negar, et al.
Publicado: (2021) -
Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19
por: Abbasian, Ladan, et al.
Publicado: (2022) -
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
por: Davoudi-Monfared, Effat, et al.
Publicado: (2020) -
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial
por: Rahmani, Hamid, et al.
Publicado: (2020) -
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial
por: Nekoukar, Zahra, et al.
Publicado: (2021)